What if you invested $1000 in MRK on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Merck & Co., Inc. has delivered an average annual return of 11.8%. The stock peaked in 2022 with a massive +49.0% gain, while investors faced a downturn in 2008 (-44.6%). Overall, the stock finished in the green 15 times out of 20 years.
Avg Return
+11.8%
Win Rate
75%
15W - 5L
Best
+49.0%
2022
Worst
-44.6%
2008
Performance Consistency
About Merck & Co., Inc.
Visit Website ↗Merck & Co., known as MSD outside the United States and Canada, is a global healthcare company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products.
Key Business Segments
Pharmaceutical
Keytruda, Gardasil, Januvia.
Animal Health
Veterinary pharmaceuticals and vaccines.
Key Innovations
- ✓Keytruda (cancer immunotherapy)
- ✓Gardasil (HPV vaccine)
- ✓Molnupiravir (COVID-19 antiviral)
Historical Milestones
Founded as a US subsidiary of German Merck.
Established as an independent American company.
Merged with Schering-Plough.